NGS in the Field of Precision Medicine-Oncology

What’s in the eBook

Genome sequencing has dramatically changed the way we diagnose and treat diseases. Whereas in the past, treatment selection for oncology patients was based on imaging technologies and histology, it is now becoming more and more common to include genomic testing during the decision-making process.

Next-Generation Sequencing (NGS) is becoming the preferred genomic testing method in the medical practice. Furthermore, the (bio)pharmaceutical industry is now strongly focusing on the use of genetic biomarkers as a way to select patients most likely to respond to their new therapeutic drugs.

At Hamilton, we have closely followed the trends and impact of NGS in the oncology field and we have been quick to recognize our customers' automation needs in order to adopt this technology. In this eBook, we discuss the impact of NGS in precision medicine (PM)-oncology, the drivers behind the need for automation during the sample preparation for NGS, and the solutions that Hamilton offers to customers working in this field.

Read the full eBook to learn more.